Lapatinib Completed Phase 1 Trials for Advanced or Metastatic ErbB2-overexpressing Breast Cancer / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00462956GW572016 In Patients With Advanced Or Metastatic Breast Cancer
NCT00849329A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
NCT00790816Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
NCT00996762A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
NCT00371488GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer